The antibodies, cytotoxic drugs, and linkers of ADC are the key elements in ADC design. The linker is a bridge between antibody and cytotoxic drugs. The ideal coupling must be stable in vitro or in the blood circulation to prevent systemic toxicity caused by the early release of cytotoxic drugs, and at the same time can enter and kill the cancer cells by quickly releasing effective cytotoxic drugs .
